Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Localization of the ventricular pacing site from BSPM and standard 12-lead ECG: a comparison study

KA. Sedova, PM. van Dam, M. Blahova, L. Necasova, J. Kautzner

. 2023 ; 13 (1) : 9618. [pub] 20230614

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Inverse ECG imaging methods typically require 32-250 leads to create body surface potential maps (BSPM), limiting their routine clinical use. This study evaluated the accuracy of PaceView inverse ECG method to localize the left or right ventricular (LV and RV, respectively) pacing leads using either a 99-lead BSPM or the 12-lead ECG. A 99-lead BSPM was recorded in patients with cardiac resynchronization therapy (CRT) during sinus rhythm and sequential LV/RV pacing. The non-contrast CT was performed to localize precisely both ECG electrodes and CRT leads. From a BSPM, nine signals were selected to obtain the 12-lead ECG. Both BSPM and 12-lead ECG were used to localize the RV and LV lead, and the localization error was calculated. Consecutive patients with dilated cardiomyopathy, previously implanted with a CRT device, were enrolled (n = 19). The localization error for the RV/LV lead was 9.0 [IQR 4.8-13.6] / 7.7 [IQR 0.0-10.3] mm using the 12-lead ECG and 9.1 [IQR 5.4-15.7] / 9.8 [IQR 8.6-13.1] mm for the BSPM. Thus, the noninvasive lead localization using the 12-lead ECG was accurate enough and comparable to 99-lead BSPM, potentially increasing the capability of 12-lead ECG for the optimization of the LV/RV pacing sites during CRT implant or for the most favorable programming.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23011052
003      
CZ-PrNML
005      
20230801132800.0
007      
ta
008      
230718s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-023-36768-z $2 doi
035    __
$a (PubMed)37316547
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Sedova, Ksenia A $u Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University in Prague, Sitna Sq. 3105, 27201, Kladno, Czech Republic. ksenia.sedova@fbmi.cvut.cz
245    10
$a Localization of the ventricular pacing site from BSPM and standard 12-lead ECG: a comparison study / $c KA. Sedova, PM. van Dam, M. Blahova, L. Necasova, J. Kautzner
520    9_
$a Inverse ECG imaging methods typically require 32-250 leads to create body surface potential maps (BSPM), limiting their routine clinical use. This study evaluated the accuracy of PaceView inverse ECG method to localize the left or right ventricular (LV and RV, respectively) pacing leads using either a 99-lead BSPM or the 12-lead ECG. A 99-lead BSPM was recorded in patients with cardiac resynchronization therapy (CRT) during sinus rhythm and sequential LV/RV pacing. The non-contrast CT was performed to localize precisely both ECG electrodes and CRT leads. From a BSPM, nine signals were selected to obtain the 12-lead ECG. Both BSPM and 12-lead ECG were used to localize the RV and LV lead, and the localization error was calculated. Consecutive patients with dilated cardiomyopathy, previously implanted with a CRT device, were enrolled (n = 19). The localization error for the RV/LV lead was 9.0 [IQR 4.8-13.6] / 7.7 [IQR 0.0-10.3] mm using the 12-lead ECG and 9.1 [IQR 5.4-15.7] / 9.8 [IQR 8.6-13.1] mm for the BSPM. Thus, the noninvasive lead localization using the 12-lead ECG was accurate enough and comparable to 99-lead BSPM, potentially increasing the capability of 12-lead ECG for the optimization of the LV/RV pacing sites during CRT implant or for the most favorable programming.
650    _2
$a lidé $7 D006801
650    12
$a srdeční resynchronizační terapie $7 D058406
650    _2
$a prostředky srdeční resynchronizační terapie $7 D058409
650    12
$a dilatační kardiomyopatie $7 D002311
650    _2
$a elektrokardiografie $7 D004562
650    _2
$a elektrody $7 D004566
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a van Dam, Peter M $u Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands
700    1_
$a Blahova, Marie $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Necasova, Lucie $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Kautzner, Josef $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 13, č. 1 (2023), s. 9618
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37316547 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20230801132757 $b ABA008
999    __
$a ok $b bmc $g 1963454 $s 1197317
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 13 $c 1 $d 9618 $e 20230614 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
LZP    __
$a Pubmed-20230718

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...